AC Rawstron, G Laycock-Brown, G Hale, FE Davies, GJ Morgan, JA Child, P Hillmen and RG Owen (2006) “CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy”, Haematologica. Pavia, Italy, 91(11), pp. 1577-1578. doi: 10.3324/%x.